CCER1
gene geneOn this page
Also known as MGC26598
Summary
CCER1 (coiled-coil glutamate rich protein 1, HGNC:28373) is a protein-coding gene on chromosome 12q21.33, encoding Coiled-coil domain-containing glutamate-rich protein 1 (Q8TC90). Regulator of histone epigenetic modifications and chromatin compaction into the sperm head, required for histone-to-protamine (HTP) transition.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_152638
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28373 |
| Approved symbol | CCER1 |
| Name | coiled-coil glutamate rich protein 1 |
| Location | 12q21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC26598 |
| Ensembl gene | ENSG00000197651 |
| Ensembl biotype | protein_coding |
| OMIM | 620881 |
| Entrez | 196477 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000358859, ENST00000548187, ENST00000549707
RefSeq mRNA: 1 — MANE Select: NM_152638
NM_152638
CCDS: CCDS9036
Canonical transcript exons
ENST00000358859 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001409306 | 90952215 | 90955176 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 94.04.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0978 / max 110.5158, expressed in 4 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 132529 | 0.0978 | 4 |
Top tissues by expression
217 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 94.04 | gold quality |
| left testis | UBERON:0004533 | 93.06 | gold quality |
| right testis | UBERON:0004534 | 92.82 | gold quality |
| testis | UBERON:0000473 | 90.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.53 | gold quality |
| adult organism | UBERON:0007023 | 76.66 | gold quality |
| kidney epithelium | UBERON:0004819 | 73.41 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 69.32 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 69.15 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 68.68 | gold quality |
| upper arm skin | UBERON:0004263 | 68.24 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 64.63 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 64.12 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 63.54 | gold quality |
| myocardium | UBERON:0002349 | 58.22 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 57.28 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 56.13 | gold quality |
| biceps brachii | UBERON:0001507 | 56.11 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 55.57 | gold quality |
| jejunal mucosa | UBERON:0000399 | 55.34 | gold quality |
| colonic mucosa | UBERON:0000317 | 54.22 | gold quality |
| quadriceps femoris | UBERON:0001377 | 54.18 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 54.13 | gold quality |
| vastus lateralis | UBERON:0001379 | 53.84 | gold quality |
| vena cava | UBERON:0004087 | 53.67 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.24 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 53.21 | gold quality |
| lower lobe of lung | UBERON:0008949 | 53.13 | silver quality |
| cauda epididymis | UBERON:0004360 | 52.28 | gold quality |
| corpus epididymis | UBERON:0004359 | 52.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
73 targeting CCER1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-12117 | 99.50 | 67.57 | 868 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
Literature-anchored findings (GeneRIF, showing 1)
- Phase-separated CCER1 coordinates the histone-to-protamine transition and male fertility. (PMID:38081819)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccer1 | ENSMUSG00000047025 |
| rattus_norvegicus | Ccer1 | ENSRNOG00000004875 |
Protein
Protein identifiers
Coiled-coil domain-containing glutamate-rich protein 1 — Q8TC90 (reviewed: Q8TC90)
All UniProt accessions (2): H0YHB9, Q8TC90
UniProt curated annotations — full annotation on UniProt →
Function. Regulator of histone epigenetic modifications and chromatin compaction into the sperm head, required for histone-to-protamine (HTP) transition. HTP is a key event in which somatic histones are first replaced by testis-specific histone variants, then transition proteins (TNPs) are incorporated into the spermatid nucleus, and finally protamines (PRMs) replace the TNPs to promote chromatin condensation.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_689851* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027889 | CCER1 | Family |
| IPR052696 | Coiled-coil_domain | Family |
Pfam: PF15482
UniProt features (15 total): region of interest 4, compositionally biased region 4, sequence variant 4, coiled-coil region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TC90-F1 | 50.34 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 72 (showing top):
GOBP_MALE_GAMETE_GENERATION, HATADA_METHYLATED_IN_LUNG_CANCER_DN, chr12q21, GOBP_NUCLEUS_ORGANIZATION, E4F1_Q6, HNF4_01, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION, VDR_Q3, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GCCNNNWTAAR_UNKNOWN, MYC_Q2, ATAAGCT_MIR21, MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3, GOBP_SPERM_DNA_CONDENSATION
GO Biological Process (3): spermatogenesis (GO:0007283), sperm DNA condensation (GO:0035092), cell differentiation (GO:0030154)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| chromatin organization | 1 |
| spermatid nucleus differentiation | 1 |
| cellular developmental process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
484 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCER1 | CIMIP4 | O43247 | 642 |
| CCER1 | MORN5 | Q5VZ52 | 594 |
| CCER1 | GARIN5A | Q6IPT2 | 507 |
| CCER1 | OR2T29 | Q8NH02 | 505 |
| CCER1 | PEBP4 | Q96S96 | 471 |
| CCER1 | OR5H2 | Q8NGV7 | 447 |
| CCER1 | OR2M4 | Q96R27 | 446 |
| CCER1 | F2Z2I4 | F2Z2I4 | 445 |
| CCER1 | DEFB130A | P0DP74 | 438 |
| CCER1 | GARIN1B | Q96KD3 | 415 |
| CCER1 | PRAMEF2 | O60811 | 412 |
| CCER1 | TMCO5A | Q8N6Q1 | 401 |
| CCER1 | OR7D4 | Q8NG98 | 391 |
| CCER1 | CCDC192 | P0DO97 | 390 |
| CCER1 | MORN3 | Q6PF18 | 388 |
IntAct
39 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOTCH2NLA | CCER1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CCER1 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT31 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCER1 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| NOTCH2NLC | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCER1 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCER1 | KRTAP4-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-2 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCER1 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLSCR1 | CCER1 | psi-mi:“MI:0915”(physical association) | 0.550 |
| MDFI | CCER1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| RBPMS | CCER1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CCER1 | NOTCH2NLC | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCER1 | KRTAP6-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCER1 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): CCER1 (Two-hybrid), CCER1 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), CCER1 (Two-hybrid), CCER1 (Two-hybrid), CCER1 (Two-hybrid), CCER1 (Two-hybrid), CCER1 (Two-hybrid), KRTAP9-3 (Two-hybrid), KRTAP6-3 (Two-hybrid), KRTAP4-2 (Two-hybrid), NOTCH2NL (Two-hybrid), NBPF19 (Two-hybrid), CCER1 (Affinity Capture-RNA)
ESM2 similar proteins: A0A1B0GVQ3, A1A519, A6NMN3, A6QQS3, A7XCE8, D3ZAP3, E9PXT9, F1N8V3, O08550, O35668, O73823, P0C7A2, P0C7M4, P25483, P54256, P54257, Q01538, Q08050, Q0P670, Q2T9P9, Q32LN6, Q32MG2, Q5BI31, Q5REX1, Q5VWQ0, Q60542, Q64318, Q66LM5, Q66LM6, Q6AXV6, Q6NWJ0, Q6ZVD7, Q7Z2Y5, Q80T69, Q80YD3, Q8BJS7, Q8CCG1, Q8IV76, Q8NA61, Q8NA70
Diamond homologs: Q2T9P9, Q6AY45, Q8TC90, Q9CQL2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
237 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:90953679:T:TA | donor_gain | 0.9600 |
| 12:90953680:C:A | donor_gain | 0.9100 |
| 12:90953701:CCAGG:C | donor_gain | 0.9000 |
| 12:90952920:C:CC | acceptor_gain | 0.8600 |
| 12:90954992:C:CC | acceptor_gain | 0.8100 |
| 12:90952918:CA:C | acceptor_gain | 0.7900 |
| 12:90954988:GGGGC:G | acceptor_gain | 0.7900 |
| 12:90954987:TGGGG:T | acceptor_gain | 0.7800 |
| 12:90955131:C:CA | donor_gain | 0.7600 |
| 12:90953709:T:TA | donor_gain | 0.7500 |
| 12:90952915:TAGCA:T | acceptor_gain | 0.7300 |
| 12:90953715:T:TA | donor_gain | 0.7200 |
| 12:90954991:GC:G | acceptor_loss | 0.7200 |
| 12:90954993:T:C | acceptor_loss | 0.7200 |
| 12:90953578:T:C | donor_gain | 0.7100 |
| 12:90954988:GGGG:G | acceptor_gain | 0.7100 |
| 12:90953775:TCG:T | donor_gain | 0.7000 |
| 12:90954990:GG:G | acceptor_gain | 0.7000 |
| 12:90954994:G:C | acceptor_loss | 0.6800 |
| 12:90955118:GTTAC:G | donor_loss | 0.6800 |
| 12:90955119:TTA:T | donor_loss | 0.6800 |
| 12:90955120:TACC:T | donor_loss | 0.6800 |
| 12:90955121:ACC:A | donor_loss | 0.6800 |
| 12:90955122:C:A | donor_loss | 0.6800 |
| 12:90955123:C:A | donor_loss | 0.6800 |
| 12:90953658:T:TA | donor_gain | 0.6700 |
| 12:90954991:GCT:G | acceptor_gain | 0.6700 |
| 12:90955117:AGTT:A | donor_loss | 0.6600 |
| 12:90954989:GGGC:G | acceptor_gain | 0.6100 |
| 12:90954996:G:GC | acceptor_gain | 0.6000 |
AlphaMissense
2672 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:90954167:G:C | F192L | 0.996 |
| 12:90954167:G:T | F192L | 0.996 |
| 12:90954169:A:G | F192L | 0.996 |
| 12:90954168:A:G | F192S | 0.987 |
| 12:90954161:C:A | M194I | 0.986 |
| 12:90954161:C:G | M194I | 0.986 |
| 12:90954161:C:T | M194I | 0.986 |
| 12:90954165:A:C | I193S | 0.985 |
| 12:90954165:A:G | I193T | 0.983 |
| 12:90954165:A:T | I193N | 0.981 |
| 12:90954168:A:C | F192C | 0.976 |
| 12:90954156:T:G | Q196P | 0.972 |
| 12:90954162:A:G | M194T | 0.971 |
| 12:90954153:A:C | I197S | 0.964 |
| 12:90954153:A:G | I197T | 0.961 |
| 12:90954177:G:A | T189I | 0.951 |
| 12:90954159:T:A | N195I | 0.941 |
| 12:90954169:A:T | F192I | 0.940 |
| 12:90954174:G:A | T190I | 0.940 |
| 12:90954140:C:A | M201I | 0.936 |
| 12:90954140:C:G | M201I | 0.936 |
| 12:90954140:C:T | M201I | 0.936 |
| 12:90954170:T:A | Q191H | 0.934 |
| 12:90954170:T:G | Q191H | 0.934 |
| 12:90954141:A:G | M201T | 0.928 |
| 12:90954144:T:A | D200V | 0.927 |
| 12:90954179:G:C | N188K | 0.927 |
| 12:90954179:G:T | N188K | 0.927 |
| 12:90954169:A:C | F192V | 0.924 |
| 12:90954145:C:G | D200H | 0.918 |
dbSNP variants (sampled 300 via entrez): RS1000038557 (12:90955320 T>C), RS1000713090 (12:90952799 G>A), RS1001102676 (12:90952404 A>G), RS1001439686 (12:90955882 A>G), RS1003809395 (12:90954628 G>T), RS1004729720 (12:90953540 T>G), RS1006289318 (12:90955643 A>G), RS1007485841 (12:90956327 GTTTCATTATA>G), RS1007710238 (12:90956439 T>G), RS1007742794 (12:90956727 A>G), RS1008230206 (12:90955501 G>A), RS1008243570 (12:90953485 T>A), RS1008346110 (12:90955351 G>C), RS1009713698 (12:90957117 T>C), RS1010189721 (12:90955354 G>A,C)
Disease associations
OMIM: gene MIM:620881 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003996_9 | Monobrow | 2.000000e-12 |
| GCST007565_169 | Morning person | 1.000000e-14 |
| GCST007565_25 | Morning person | 5.000000e-16 |
| GCST007576_60 | Chronotype | 5.000000e-16 |
| GCST010989_45 | Body size at age 10 | 9.000000e-09 |
| GCST012490_372 | Femur bone mineral density x serum urate levels interaction | 3.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007906 | synophrys measurement |
| EFO:0008328 | chronotype measurement |
| EFO:0009819 | comparative body size at age 10, self-reported |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol S | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.